Astal Laboratories last traded at ₹67.00 (2026-10-13). Over the past month the stock moved -11.5%, three months the stock moved -8.5%, year the stock moved -23.3%. Its closing range over 52 weeks is ₹62.13 – ₹100.56, with the latest close 33.4% below the high.
Closing prices up to 2026-10-13.
Astal Laboratories Ltd is engaged in Manufacturing and Trading of all kinds of active Pharmaceutical Ingredients (Bulk Drugs).[1]
Business Update[1] Astal Laboratories Limited (formerly Macro International Limited) was taken over in 2022 under SEBI takeover regulations, following which its objects were changed to manufacturing and sale of pharmaceutical intermediates and bulk drugs. The name was subsequently changed to Astal Laboratories Limited in May 2024.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 100.94 | 12.25 | 12.14 | 9.42 | 2.15 |
| Mar 2026 | 134.05 | 10.19 | 7.60 | 7.68 | 1.82 |
| Dec 2025 | 52.24 | 3.55 | 6.80 | 2.36 | 2.19 |
| Mar 2025 | 23.47 | 4.18 | 17.81 | 2.74 | 2.79 |
In the latest year (Mar 2026), Astal Laboratories reported sales of ₹249.00 crore (+287.7%) and net profit of ₹15.00 crore (+68.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 249.00 | 21.00 | 8.00 | 15.00 | 3.48 |
| Mar 2025 | 64.23 | 12.77 | 19.88 | 8.93 | 5.06 |
| Mar 2024 | 23.65 | 1.12 | 4.74 | 0.78 | 0.79 |
| Mar 2023 | 3.43 | -0.14 | -4.08 | 0.02 | 0.05 |
| Mar 2022 | 0.00 | -0.20 | – | -0.02 | -0.05 |
| Mar 2021 | 0.20 | 0.02 | 10.00 | 0.01 | 0.03 |
| Mar 2020 | 0.00 | -0.21 | – | -0.03 | -0.08 |
| Mar 2019 | 0.00 | -0.36 | – | -0.08 | -0.20 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | – | -100.0% | – | +589.5% | +171.6% | +287.7% |
| Operating profit growth | – | – | – | -1100.0% | – | – | +1040.2% | +64.4% |
| Net profit growth | – | – | – | -300.0% | – | +3800.0% | +1044.9% | +68.0% |
| EPS growth | – | – | – | -266.7% | – | +1480.0% | +540.5% | -31.2% |
| OPM % | – | – | 10.0% | – | -4.1% | 4.7% | 19.9% | 8.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Astal Laboratories.
Get Free AI Stock Analysis FREE →Astal Laboratories consolidated net profit rises 180.29% in the March 2026 quarter - Business Standard
Astal Laboratories shares were last quoted at ₹67.00 (-1.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Astal Laboratories has a price-to-earnings (P/E) ratio of 30.74 and a price-to-book (P/B) ratio of 0.90. The industry P/E is 52.82.
The 52-week high of Astal Laboratories is ₹103.20 and the 52-week low is ₹60.45.
The market capitalisation of Astal Laboratories is about ₹299.77 crore.
Promoters hold about 4.53% of Astal Laboratories.
Astal Laboratories belongs to the Trading sector.